Stay updated on Sitravatinib Combo Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.

Latest updates to the Sitravatinib Combo Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error rather than the study record.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record. Consequently, the study details and related sections are no longer visible and are replaced by the error page content.SummaryDifference18%

- Check25 days agoChange DetectedThe page's revision tag was updated to v3.7.0, replacing the previous v3.6.6 and indicating an updated version of the study documentation.SummaryDifference0.1%

- Check39 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, signaling a small metadata update to the study record.SummaryDifference0.1%

- Check60 days agoChange DetectedResults were posted on 2026-08-04 for the study, adding a 'Results Posted' section with safety and outcome details, including the number of participants with treatment-related adverse events, treatment discontinuations due to AEs, and clinically significant laboratory abnormalities, along with the associated results dates and documents. The previous result measures such as 'Frequency of subjects experiencing treatment-related AEs' and 'Time to clinical or radiographic progression' were removed.SummaryDifference2%

- Check75 days agoChange DetectedThe page's revision reference was updated from v3.6.3 to v3.6.4, indicating a new revision of the page's template or metadata.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib Combo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.